Lonza · 2 weeks ago
QA Specialist III-Operations
Lonza is a global leader in life sciences dedicated to enabling a healthier world. As a Quality Assurance Specialist III, you will play a key role in reviewing and approving GMP documentation to support operations and ensure compliance.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Review and approve GMP documentation for site operations
Serve as QA Subject Matter Expert for equipment and validation documents
Ensure compliance with Lonza documentation standards and procedures
Collaborate with internal teams to resolve documentation issues
Participate in interdepartmental projects and routine meetings
Apply data integrity principles in all aspects of work
Provide training and mentorship to junior team members
Qualification
Required
Bachelor's degree in a scientific field
5-10 years of experience in Quality Assurance and GMP environments
Strong understanding of GMP regulations and documentation processes
Excellent communication and collaboration skills
Ability to manage multiple priorities effectively
Proficiency in enterprise systems and Microsoft Office tools
Business fluent in English
Benefits
Competitive salary and comprehensive benefits package
Opportunities for professional growth and development
Collaborative and inclusive work environment
Access to cutting-edge technologies and global projects
Support for work-life balance
Employee recognition programs
Health and wellness initiatives
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase